Global Wealth Strategies & Associates’s AbbVie ABBV Stock Holding History

Global Wealth Strategies & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$389K	Buy	1,486 +157	+12%	+$40.2K	0.07%	70
2026 Q2	$334K	Sell	1,329 -42	-3%	-$9.04K	0.06%	70
2026 Q1	$298K	Sell	1,371 -66	-5%	-$14.6K	0.07%	64
2025 Q4	$328K	Buy	1,437 +452	+46%	+$103K	0.08%	57
2025 Q3	$228K	Buy	985 +733	+291%	+$149K	0.06%	67
2025 Q2	$46.8K	Hold	252	–	–	0.01%	119
2025 Q1	$52.8K	Sell	252 -220	-47%	-$42.8K	0.02%	112
2024 Q4	$83.9K	Buy	472 +34	+8%	+$6.25K	0.03%	80
2024 Q3	$86.5K	Buy	438 +20	+5%	+$3.73K	0.03%	67
2024 Q2	$71.7K	Hold	418	–	–	0.03%	72
2024 Q1	$76.1K	Hold	418	–	–	0.03%	68
2023 Q4	$64.8K	Hold	418	–	–	0.03%	71
2023 Q3	$62.3K	Hold	418	–	–	0.03%	69
2023 Q2	$56.3K	Hold	418	–	–	0.03%	73
2023 Q1	$66.6K	Hold	418	–	–	0.03%	66
2022 Q4	$67.6K	Buy	+418	New	+$64.1K	0.04%	69

Other funds holding ABBV

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Global Wealth Strategies & Associates's ABBV Position: Q3 2026 in Review

Global Wealth Strategies & Associates increased its AbbVie (ABBV) stake by 12% in Q3 2026, buying an estimated $40.2K and bringing the position to 1,486 shares worth $389K. The position accounts for 0.07% of the portfolio, ranked #70.

Global Wealth Strategies & Associates first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 710 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Global Wealth Strategies & Associates held 1,486 shares of AbbVie worth $389K as of Q3 2026.
Global Wealth Strategies & Associates bought 157 AbbVie shares in Q3 2026, an estimated $40.2K.
AbbVie made up 0.07% of Global Wealth Strategies & Associates's portfolio in Q3 2026, its #70 holding.
Global Wealth Strategies & Associates first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
710 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q3 2026, filed 2 Oct 2026.